These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 15216467

  • 1. Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide.
    Dell'Acqua G, Giacometti A, Cirioni O, Ghiselli R, Saba V, Scalise G, Gov Y, Balaban N.
    J Infect Dis; 2004 Jul 15; 190(2):318-20. PubMed ID: 15216467
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
    Cirioni O, Giacometti A, Ghiselli R, Dell'Acqua G, Gov Y, Kamysz W, Lukasiak J, Mocchegiani F, Orlando F, D'Amato G, Balaban N, Saba V, Scalise G.
    Circulation; 2003 Aug 12; 108(6):767-71. PubMed ID: 12885754
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevention of staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP.
    Balaban N, Stoodley P, Fux CA, Wilson S, Costerton JW, Dell'Acqua G.
    Clin Orthop Relat Res; 2005 Aug 12; (437):48-54. PubMed ID: 16056025
    [Abstract] [Full Text] [Related]

  • 10. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
    Giacometti A, Cirioni O, Ghiselli R, Dell'Acqua G, Orlando F, D'Amato G, Mocchegiani F, Silvestri C, Del Prete MS, Rocchi M, Balaban N, Saba V, Scalise G.
    Peptides; 2005 Feb 12; 26(2):169-75. PubMed ID: 15629527
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci.
    Lee JY, Ko KS, Peck KR, Oh WS, Song JH.
    J Antimicrob Chemother; 2006 Jun 12; 57(6):1110-5. PubMed ID: 16556639
    [Abstract] [Full Text] [Related]

  • 16. RNAIII Inhibiting Peptide (RIP) and Derivatives as Potential Tools for the Treatment of S. aureus Biofilm Infections.
    Ciulla M, Di Stefano A, Marinelli L, Cacciatore I, Di Biase G.
    Curr Top Med Chem; 2018 Jun 12; 18(24):2068-2079. PubMed ID: 30345922
    [Abstract] [Full Text] [Related]

  • 17. Treatment efficacy of the lead RNAIII-inhibiting peptide YSPWTNF-NH2 in acquired Staphylococcus aureus sepsis: a histopathological assessment.
    Ribeiro PD, Ribeiro OD, Marcolan AM, Medina-Acosta E.
    Peptides; 2003 Nov 12; 24(11):1829-36. PubMed ID: 15019216
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. RNAIII-inhibiting peptide affects biofilm formation in a rat model of staphylococcal ureteral stent infection.
    Cirioni O, Ghiselli R, Minardi D, Orlando F, Mocchegiani F, Silvestri C, Muzzonigro G, Saba V, Scalise G, Balaban N, Giacometti A.
    Antimicrob Agents Chemother; 2007 Dec 12; 51(12):4518-20. PubMed ID: 17875996
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.